Wealth Alliance LLC acquired a new stake in Ryan Specialty Holdings Inc. (NYSE:RYAN - Free Report) during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 4,108 shares of the company's stock, valued at approximately $303,000.
A number of other hedge funds and other institutional investors have also recently bought and sold shares of the business. Corient Private Wealth LLC raised its holdings in Ryan Specialty by 12.8% in the fourth quarter. Corient Private Wealth LLC now owns 18,103 shares of the company's stock worth $1,162,000 after purchasing an additional 2,055 shares during the period. Thrivent Financial for Lutherans raised its holdings in Ryan Specialty by 5.7% in the fourth quarter. Thrivent Financial for Lutherans now owns 29,373 shares of the company's stock worth $1,917,000 after purchasing an additional 1,573 shares during the period. Harvest Fund Management Co. Ltd acquired a new stake in Ryan Specialty in the fourth quarter worth $54,000. Commonwealth of Pennsylvania Public School Empls Retrmt SYS raised its holdings in Ryan Specialty by 4.2% in the fourth quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 23,498 shares of the company's stock worth $1,508,000 after purchasing an additional 948 shares during the period. Finally, KLP Kapitalforvaltning AS acquired a new stake in Ryan Specialty in the fourth quarter worth $1,598,000. 84.82% of the stock is owned by institutional investors.
Wall Street Analysts Forecast Growth
Several equities research analysts have weighed in on the stock. Barclays cut their target price on shares of Ryan Specialty from $83.00 to $79.00 and set an "overweight" rating on the stock in a report on Monday, July 7th. The Goldman Sachs Group upgraded shares of Ryan Specialty from a "neutral" rating to a "buy" rating and raised their price objective for the stock from $74.00 to $81.00 in a report on Tuesday, May 13th. Morgan Stanley dropped their price objective on shares of Ryan Specialty from $80.00 to $78.00 and set an "overweight" rating on the stock in a report on Monday, July 14th. Wells Fargo & Company dropped their price objective on shares of Ryan Specialty from $65.00 to $63.00 and set an "equal weight" rating on the stock in a report on Thursday, July 10th. Finally, Keefe, Bruyette & Woods dropped their price objective on shares of Ryan Specialty from $76.00 to $75.00 and set an "outperform" rating on the stock in a report on Wednesday, April 9th. One investment analyst has rated the stock with a sell rating, three have given a hold rating and eight have given a buy rating to the company. According to MarketBeat.com, Ryan Specialty presently has a consensus rating of "Moderate Buy" and an average price target of $74.83.
View Our Latest Research Report on Ryan Specialty
Ryan Specialty Stock Down 1.3%
Shares of RYAN stock opened at $65.21 on Tuesday. The company has a current ratio of 1.05, a quick ratio of 1.05 and a debt-to-equity ratio of 3.45. Ryan Specialty Holdings Inc. has a 1 year low of $56.59 and a 1 year high of $77.16. The firm's fifty day moving average price is $67.72 and its two-hundred day moving average price is $68.24. The firm has a market capitalization of $17.11 billion, a P/E ratio of 191.78, a PEG ratio of 1.79 and a beta of 0.66.
Ryan Specialty (NYSE:RYAN - Get Free Report) last issued its quarterly earnings results on Thursday, May 1st. The company reported $0.39 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.39. Ryan Specialty had a net margin of 6.97% and a return on equity of 47.70%. The firm had revenue of $690.17 million for the quarter, compared to analyst estimates of $680.80 million. During the same period in the previous year, the business earned $0.35 EPS. The company's revenue was up 25.0% compared to the same quarter last year. On average, equities analysts predict that Ryan Specialty Holdings Inc. will post 2.29 EPS for the current fiscal year.
Ryan Specialty Dividend Announcement
The company also recently disclosed a quarterly dividend, which was paid on Tuesday, May 27th. Stockholders of record on Tuesday, May 13th were given a $0.12 dividend. This represents a $0.48 dividend on an annualized basis and a dividend yield of 0.74%. The ex-dividend date was Tuesday, May 13th. Ryan Specialty's dividend payout ratio (DPR) is presently 141.18%.
Insider Transactions at Ryan Specialty
In other news, EVP Mark Stephen Katz sold 14,377 shares of Ryan Specialty stock in a transaction dated Friday, June 13th. The shares were sold at an average price of $65.84, for a total value of $946,581.68. Following the completion of the transaction, the executive vice president owned 1,117 shares of the company's stock, valued at $73,543.28. This trade represents a 92.79% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, Director David P. Bolger sold 5,000 shares of Ryan Specialty stock in a transaction dated Tuesday, June 3rd. The shares were sold at an average price of $70.80, for a total transaction of $354,000.00. Following the completion of the transaction, the director directly owned 71,467 shares of the company's stock, valued at approximately $5,059,863.60. This trade represents a 6.54% decrease in their position. The disclosure for this sale can be found here. Company insiders own 52.21% of the company's stock.
Ryan Specialty Company Profile
(
Free Report)
Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.
Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Ryan Specialty, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ryan Specialty wasn't on the list.
While Ryan Specialty currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.